Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: Correlation of serum complement factor 5a level with inflammatory response and cognitive function in patients with Alzheimer’s disease of different severity

Fig. 2

The difference of serum C5a level between mild, moderate and severe AD patients. (A) Serum C5a level was determined by ELISA; (B) The ROC curve of serum C5a level for severe AD evaluation; (C) Kaplan-Meier curve was employed to analyze the cumulative incidence of severe AD. Data in panel A were tested by independent t test. Data in panel B were analyzed using the ROC curve. * P < 0.05

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us